| 000 | 01345 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513065909.0 | ||
| 264 | 0 | _c19940104 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0010-6178 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBelliveau, P | |
| 245 | 0 | 0 |
_aOral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy. _h[electronic resource] |
| 260 |
_bConnecticut medicine _cAug 1993 |
||
| 300 |
_a539-45 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aCiprofloxacin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 |
_aGram-Negative Aerobic Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aGram-Positive Cocci _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOfloxacin _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNightingale, C H | |
| 700 | 1 | _aQuintiliani, R | |
| 700 | 1 | _aCrowe, H | |
| 700 | 1 | _aGousee, G | |
| 773 | 0 |
_tConnecticut medicine _gvol. 57 _gno. 8 _gp. 539-45 |
|
| 999 |
_c8242365 _d8242365 |
||